Add like
Add dislike
Add to saved papers

A novel highly selective ligand for separation of actinides and lanthanides in the nuclear fuel cycle. Experimental verification of the theoretical prediction.

We have predicted earlier by DFT simulation that tridentate O,N,O-donor cyclic dilactams (B) belonging to the family of pyridine-2,6-dicarboxamides are much more selective and efficient extractants for the separation of lanthanides and actinides than open-structure pyridine-2,6-dicarboxamides due to the higher degree of "ligand preorganization". In the present work, three new ligands of type (B) were synthesized. Extraction experiments showed that, in line with the data from DFT simulation, these ligands have 5-6-fold higher selectivity for the separation of an Am3+ /Eu3+ pair and provide distribution coefficients D which are by three orders of magnitude higher than those for the related parent ligands with an open structure. Determination of the solvate numbers (SNs) for Eu3+ and Am3+ cations by slope analysis has shown that the stoichiometry of complexes, in the form of which these ions pass from the aqueous into the organic phase, depends to a considerable extent on the polarity of the organic solvent. Strongly polar solvents (ε > 20) extract these cations mainly in the form of 1 : 1 complexes LM(NO3 )3 having according to the DFT simulation the largest dipole moments (μ = 18.6-19.7 D). The solvents of low polarity (ε ≤ 10) extract these cations mainly in the form of less polar 2 : 1 complexes L2 M(NO3 )3 (μ ≈ 1.6 D). For solvents of intermediate polarity fractional values of solvate numbers were obtained which indicates the coexistence of complexes LM(NO3 )3 and L2 M(NO3 )3 in the organic phase.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app